发布求助
文献互助 智能选刊 最新文献

Revue medicale de Liege最新文献

筛选
英文 中文
[Dapagliflozin in DELIVER : confirmation of the benefit with SGLT2 inhibitors in heart failure with preserved ejection fraction]. [达格列净在DELIVER中的应用:确认SGLT2抑制剂对保留射血分数的心力衰竭的益处]。
Revue medicale de Liege Pub Date : 2023-02-01
André Scheen, Patrizio Lancellotti
{"title":"[Dapagliflozin in DELIVER : confirmation of the benefit with SGLT2 inhibitors in heart failure with preserved ejection fraction].","authors":"André Scheen,&nbsp;Patrizio Lancellotti","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Gliflozins (sodium-glucose cotransporter type 2 inhibitors or SGLT2is) first demonstrated a reduction in hospitalisation for heart failure (hHF) in patients with type 2 diabetes (T2DM) at high cardiovascular risk. Then, a reduction in hHF (also combined with cardiovascular mortality) was reported in patients with heart failure, independently of the presence of T2DM. These placebo-controlled trials first concerned patients with heart failure and reduced left ventricular ejection fraction (LVEF) in DAPA-HF with dapagliflozin and EMPEROR-Reduced with empagliflozin. Afterwards, the benefit was observed in patients with preserved LVEF in EMPEROR-Preserved with empagliflozin, yet some doubt persisted in patients with LVEF > 60 %. The DELIVER study recently confirmed a significant reduction in the composite outcome hHF plus cardiovascular mortality (- 27 %) and in hHF (- 21 %) in patients (with or without T2DM) with heart failure and mildly reduced or preserved LVEF treated with dapagliflozin compared with placebo. The protection was noticed whatever the level of LVEF. These results reinforce the place of SGLT2is in international guidelines for the prevention or treatment of heart failure independently of the level of LVEF. SGLT2is represent the first pharmacological class that has proven its efficacy in patients with heart failure and preserved LVEF.</p>","PeriodicalId":21414,"journal":{"name":"Revue medicale de Liege","volume":"78 2","pages":"79-84"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9315499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Reexpansion edema : complication of pleural effusion drainage]. 再扩张水肿:胸腔积液引流并发症。
Revue medicale de Liege Pub Date : 2023-02-01
Maxime Marquet, Xavier Bertrand
{"title":"[Reexpansion edema : complication of pleural effusion drainage].","authors":"Maxime Marquet,&nbsp;Xavier Bertrand","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Reexpansion pulmonary edema is a rare complication of pleural effusion drainage (liquid or gas). Its pathophysiology is not fully understood but it seems to be induced by an increase in the permeability of the alveolar-capillary membrane. The purpose of this case report is to present the clinic of reexpansion edema and also to provide practitioners with a management strategy.</p>","PeriodicalId":21414,"journal":{"name":"Revue medicale de Liege","volume":"78 2","pages":"63-64"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9315498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[How I explore … affective instability]. [我如何探索……情感不稳定]。
Revue medicale de Liege Pub Date : 2023-02-01
Laura Marrocco, Cécile Debabeche, Gabrielle Scantamburlo
{"title":"[How I explore … affective instability].","authors":"Laura Marrocco,&nbsp;Cécile Debabeche,&nbsp;Gabrielle Scantamburlo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Affective instability is a common phenomenon in adults. It may be the expression of underlying organic or psychiatric conditions. This is a potentially disabling symptom for the individual, which can cause psychological distress and even consequences in daily life functioning. This article is intended for any healthcare professional and aims to clarify the assessment and diagnostic approach to a patient with mood swings.</p>","PeriodicalId":21414,"journal":{"name":"Revue medicale de Liege","volume":"78 2","pages":"114-119"},"PeriodicalIF":0.0,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9376857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Compartmental syndrome complicating endovascular treatment of ruptured abdominal aortic aneurysm]. [室室综合征并发腹主动脉瘤破裂的血管内治疗]。
Revue medicale de Liege Pub Date : 2023-01-01
L Levavasseur, F Salomez, A Paulmier, C Mettlen, P Kapinga, C Vazquez
{"title":"[Compartmental syndrome complicating endovascular treatment of ruptured abdominal aortic aneurysm].","authors":"L Levavasseur,&nbsp;F Salomez,&nbsp;A Paulmier,&nbsp;C Mettlen,&nbsp;P Kapinga,&nbsp;C Vazquez","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The Guide Line of the Society for Vascular Surgery now recommends endovascular repair (rEVAR) for ruptured abdominal aortic aneurysms (RAAA) when anatomical conditions are present. Abdominal compartment syndrome (ACS) can be one of the serious postoperative complications of rEVAR. ACS is usually associated with progressive development of organ dysfunctions and poor outcomes. We describe an ACS following a RAAA with hemorrhagic shock treated conservatively with a rEVAR.Decompression laparotomy were not performed because spontaneous improvement with conservative ICU treatment was effective.</p>","PeriodicalId":21414,"journal":{"name":"Revue medicale de Liege","volume":"78 1","pages":"17-20"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9094865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[A new era for glucagon-like peptide-1 receptor agonists]. 胰高血糖素样肽-1受体激动剂的新时代。
Revue medicale de Liege Pub Date : 2023-01-01
M F Neuville, N Paquot, A J Scheen
{"title":"[A new era for glucagon-like peptide-1 receptor agonists].","authors":"M F Neuville,&nbsp;N Paquot,&nbsp;A J Scheen","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Glucagon-like peptide-1 (GLP-1) receptor agonists have a privileged place in the management of type 2 diabetes (T2D). They not only improve glucose control without inducing hypoglycaemia and trigger weight loss, but also protect against atherosclerotic cardiovascular disease. Increasing the dose of three of them (liraglutide, semaglutide, dulaglutide) allows better glycaemic results and of potential interest a greater weight reduction. Liraglutide at a daily dose of 3.0 mg and semaglutide at a weekly dose of 2.4 mg received the indication for the therapy of obesity. A recent innovation consists in the development of dual unimolecular agonists that target GLP-1 and GIP («glucose-dependent insulinotropic polypeptide») receptors (tirzepatide) or GLP-1 and glucagon receptors (cotadutide). Tirzepatide, in the SURPASS programme, showed impressive reductions in glycated haemoglobin level and body weight, greater than those observed with dulaglutide or semaglutide. Tirzepatide received the indication of the treatment of T2D and is currently tested in obesity (SURMOUNT programme). Interestingly, triagonists GIP/GLP-1/glucagon are currently developed for the management of T2D and obesity, with also perspectives for treating metabolic-associated fatty liver disease.</p>","PeriodicalId":21414,"journal":{"name":"Revue medicale de Liege","volume":"78 1","pages":"40-45"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9094861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Aseptic loosening due to osteolytic reaction to polyethylene of o total knee prosthesis]. 全膝关节假体聚乙烯溶骨反应所致无菌性松动。
Revue medicale de Liege Pub Date : 2023-01-01
P Veeckmans, P Georis, T Thirion
{"title":"[Aseptic loosening due to osteolytic reaction to polyethylene of o total knee prosthesis].","authors":"P Veeckmans,&nbsp;P Georis,&nbsp;T Thirion","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Total knee replacement (TKR) is currently the gold standard in the surgical management of degenerative knee diseases. It is a reliable operation with 95 % good results at 10 years after surgery. Aseptic loosening is the primary cause of TKR failure. It results from a periprosthetic osteolytic reaction secondary to the host's reaction to the wear particle of the prosthesis and responsible for an imbalance in osteoformation and osteolysis. Polyethylene (PE) is responsible for the majority of periprosthetic reactions but the release of metal particles may play an underestimated role with the risk of systemic manifestations. The first clinical signs appear on average 7 years after prosthesis placement. Radio-clinical assessment may be normal in the early stages. Infectious process must be systematically excluded before concluding to another type of complication.</p>","PeriodicalId":21414,"journal":{"name":"Revue medicale de Liege","volume":"78 1","pages":"12-16"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9094864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[When bariatric surgery "bypasses" controlled alcohol consumption]. [当减肥手术“绕过”控制饮酒]。
Revue medicale de Liege Pub Date : 2023-01-01
W Chakir, D Gayetot, J De Flines, J-M Triffaux
{"title":"[When bariatric surgery \"bypasses\" controlled alcohol consumption].","authors":"W Chakir,&nbsp;D Gayetot,&nbsp;J De Flines,&nbsp;J-M Triffaux","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Obesity is a complex disease with significant morbidity and mortality. Its management is a major health issue. Obesity surgery is currently the most effective treatment for this condition. However, for several years, a link between bariatric surgery and the development of an alcohol use disorder seems to be emerging. As this psychiatric complication has also a high morbidity and mortality rate, it is important to consider prevention tools to limit its occurrence and specific therapeutic approaches for its management.</p>","PeriodicalId":21414,"journal":{"name":"Revue medicale de Liege","volume":"78 1","pages":"29-34"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9094862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Refractory ischemic priapism due to trazodone]. [曲唑酮所致顽固性缺血性勃起]。
Revue medicale de Liege Pub Date : 2023-01-01
F Vaesen, M Sempels
{"title":"[Refractory ischemic priapism due to trazodone].","authors":"F Vaesen,&nbsp;M Sempels","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Priapism is a prolonged erection lasting more than four hours. In most cases, it is a surgical emergency. Trazodone is one of the molecules that can cause priapism. This constitutes a real challenge in the management of these patients, who are often young, to avoid too bad impact on erectile function. We report the case of a 34-year-old man.</p>","PeriodicalId":21414,"journal":{"name":"Revue medicale de Liege","volume":"78 1","pages":"4-6"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10531336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Integrating new migraine treatments into clinical practice (part 1) : management of acute migraine attack]. [将新的偏头痛治疗方法纳入临床实践(第一部分):急性偏头痛发作的管理]。
Revue medicale de Liege Pub Date : 2023-01-01
A Fumal, G Timmermans
{"title":"[Integrating new migraine treatments into clinical practice (part 1) : management of acute migraine attack].","authors":"A Fumal,&nbsp;G Timmermans","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Although migraine is one of the most common chronic diseases and is the subject of numerous studies, there is still a considerable proportion of patients who are not satisfied with their acute treatment. Left without any real new therapeutic option to offer patients since sumatriptan was introduced on the Belgian market 30 years ago, neurologists have recently seen a change in the therapeutic landscape with the advent of new specific acute treatments for migraine: gepants and ditans. Being the only ones currently available in Belgium, gepants (including the newly marketed rimegepant) bring added value to traditional treatments such as non-steroidal anti-inflammatory drugs and triptans. This is why it seemed useful to review the different therapeutic options available in Belgium today by including these new treatments and to propose a rational pharmacological approach to relieve acute migraine attack.</p>","PeriodicalId":21414,"journal":{"name":"Revue medicale de Liege","volume":"78 1","pages":"46-54"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9094867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[From pandemic to syndemic : the importance of context]. [从流行病到综合症:背景的重要性]。
Revue medicale de Liege Pub Date : 2023-01-01
Ph A Coucke
{"title":"[From pandemic to syndemic : the importance of context].","authors":"Ph A Coucke","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The concept of \"syndemics\" is getting more and more popularity in scientific journals, especially since the end of the first decade of the current century. It relates to the dynamic interaction of synchronous or sequential diseases (whether communicable or not, also including mental diseases), with social and environmental factors, resulting at the end in a worse global outcome. The rise of publications in peer reviewed journals is exponential, especially in the last ten years. Born after another - forgotten - epidemy, the one related to HIV (AIDS), this concept is more than ever cited within the frame of the still ongoing COVID-19 pandemics. We will highlight this concept through a couple of selected examples related to infectious diseases. The recognition of an extensive intertwining allows to change in depth the way we approach health care efficiency, both at an individual as well as a societal level.</p>","PeriodicalId":21414,"journal":{"name":"Revue medicale de Liege","volume":"78 1","pages":"7-11"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10531335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信